{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:08:27Z","timestamp":1786997307412,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["576703"],"award-info":[{"award-number":["576703"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["CVU 662463"],"award-info":[{"award-number":["CVU 662463"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.talanta.2020.121801","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T06:04:27Z","timestamp":1603433067000},"page":"121801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Microdevice immunoassay with conjugated magnetic nanoparticles for rapid anti-cyclic citrullinated peptide (anti-CCP) detection"],"prefix":"10.1016","volume":"224","author":[{"given":"Kenia Ch\u00e1vez","family":"Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Pilar Ca\u00f1izares","family":"Mac\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2020.121801_bib1","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/art.1780260813","article-title":"American rheumatism association nomenclature and classification of arthritis and rheumatism","volume":"26","author":"Decker","year":"1983","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.talanta.2020.121801_bib3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/ar1979","article-title":"Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register","volume":"8","author":"M Symmons","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.talanta.2020.121801_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2009.08.047","article-title":"Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate","volume":"209","author":"Panoulas","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.talanta.2020.121801_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/BOR.0b013e32831c5303","article-title":"Vasculitis in rheumatoid arthritis","volume":"21","author":"Turesson","year":"2009","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.talanta.2020.121801_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/08037051.2016.1172867","article-title":"The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis","volume":"5","author":"Midtbo","year":"2016","journal-title":"Blood Pres."},{"key":"10.1016\/j.talanta.2020.121801_bib7","first-page":"36","article-title":"Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis","volume":"30","author":"Wolfe","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.talanta.2020.121801_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semarthrit.2006.08.006","article-title":"Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology Criteria: a systematic review","volume":"36","author":"Alamanos","year":"2006","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.talanta.2020.121801_bib9","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria, an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"9","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.talanta.2020.121801_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/rheumatology\/kel418","article-title":"Classification criteria for rheumatoid arthritis - time to abandon rheumatoid factor?","volume":"46","author":"M Symmons","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.talanta.2020.121801_bib11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.talanta.2020.121801_bib12","first-page":"144","article-title":"Biomarkers in rheumatoid arthritis, what is new?","volume":"9","author":"Gavril\u0103","year":"2016","journal-title":"J. Med. Life."},{"key":"10.1016\/j.talanta.2020.121801_bib13","first-page":"383","article-title":"Anticitrullinated protein\/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis","volume":"60","author":"Van Venrooij","year":"2002","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.talanta.2020.121801_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","article-title":"Use and significance of anti-CCP autoantibodies in rheumatoid arthritis","volume":"45","author":"Zendman","year":"2006","journal-title":"Rehumatology"},{"key":"10.1016\/j.talanta.2020.121801_bib15","first-page":"119","article-title":"Importancia cl\u00ednica de los anticuerpos p\u00e9ptidos c\u00edclicos citrulinados en el diagn\u00f3stico de la artritis reumatoide","volume":"2","author":"Arana-Arg\u00e1ez","year":"2015","journal-title":"ReIbCi"},{"key":"10.1016\/j.talanta.2020.121801_bib16","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.biocel.2006.03.008","article-title":"Citrullination: a posttranslational modification in health and disease","volume":"38","author":"Gy\u00f6rgy","year":"2006","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.talanta.2020.121801_bib17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2217\/nnm.11.177","article-title":"Citrullination of proteins: a common post-translational modification pathway induced by different nanoparticles in vitro and in vivo","volume":"7","author":"Mohamed","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.talanta.2020.121801_bib18","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.23618","article-title":"Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis","volume":"58","author":"Kinloch","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.talanta.2020.121801_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-007-8022-5","article-title":"Anti-citrullinated protein antibodies in rheumatoid arthritis: as good as it gets? Clinic","volume":"34","author":"Szekanecz","year":"2008","journal-title":"Rev. Allerg. Immunol."},{"key":"10.1016\/j.talanta.2020.121801_bib20","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/ar1836","article-title":"Does a positive anti-CCP test identify a distinct arthritis entity?","volume":"7","author":"Skogh","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.talanta.2020.121801_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/qjmed\/hcm015","article-title":"Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis","volume":"100","author":"Niewold","year":"2007","journal-title":"Q. J. Med."},{"key":"10.1016\/j.talanta.2020.121801_bib22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1196\/annals.1443.013","article-title":"Anti-CCP antibody, a marker for the early detection of rheumatoid arthritis","volume":"1143","author":"Van Venrooij","year":"2008","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.talanta.2020.121801_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cccn.2004.12.017","article-title":"Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: analytical performance and clinical correlations","volume":"355","author":"Tampoia","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.121801_bib24","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cca.2007.08.002","article-title":"Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis","volume":"386","author":"Lutteri","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.talanta.2020.121801_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature05058","article-title":"The origins and the future of microfluidics","volume":"442","author":"Whiesides","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.talanta.2020.121801_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mee.2014.10.013","article-title":"Lab-on-a-chip devices: how to close and plug the lab?","volume":"132","author":"Temiz","year":"2015","journal-title":"Microelectron. Eng."},{"key":"10.1016\/j.talanta.2020.121801_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.protcy.2015.07.010","article-title":"Lab-on-a-chip or chip-in-a-lab: challenges of commercialization lost in translation","volume":"20","author":"Mohammed","year":"2015","journal-title":"Proc. Technol."},{"key":"10.1016\/j.talanta.2020.121801_bib28","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1039\/C6LC00387G","article-title":"A review of digital microfluidics as portable platforms for lab-on-a-chip applications","volume":"16","author":"Samiei","year":"2016","journal-title":"Lab Chip"},{"key":"10.1016\/j.talanta.2020.121801_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mee.2014.09.024","article-title":"Point-of-care testing (POCT) diagnostic systems using microfluidic lab-on-a-chip technologies","volume":"132","author":"Jung","year":"2015","journal-title":"Microelectron. Eng."},{"key":"10.1016\/j.talanta.2020.121801_bib30","first-page":"311","article-title":"Lab-on-a-chip technology: a review on design trends and future scope in biomedical applications","volume":"8","author":"Gupta","year":"2016","journal-title":"J. BioSci. Biotechnol."},{"key":"10.1016\/j.talanta.2020.121801_bib31","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1039\/b817915h","article-title":"Microfluidics and point-of-care testing","volume":"8","author":"Sia","year":"2008","journal-title":"Lab Chip"},{"key":"10.1016\/j.talanta.2020.121801_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-anchem-062012-092616","article-title":"Microfluidic chips for immunoassays","volume":"6","author":"Han","year":"2013","journal-title":"Annu. Rev. Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121801_bib33","first-page":"253","article-title":"Microfluidic immunoassays","volume":"15","author":"Lin","year":"2010","journal-title":"JALA"},{"key":"10.1016\/j.talanta.2020.121801_bib34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1080\/14686996.2016.1227222","article-title":"An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas","volume":"17","author":"Yamamichi","year":"2016","journal-title":"Sci. Technol. Adv. Mater."},{"key":"10.1016\/j.talanta.2020.121801_bib35","doi-asserted-by":"crossref","first-page":"16683","DOI":"10.1021\/acsomega.9b02788","article-title":"Rapid, sensitive, and selective detection of H5 Hemagglutinin form avian influenza virus using an Immunowall device","volume":"4","author":"Ch\u00e1vez-Ramos","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.talanta.2020.121801_bib36","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1039\/C9AN00480G","article-title":"Ultrasensitive detection of disease biomarkers using an immuno-wall device with enzymatic amplification","volume":"144","author":"Nishiyama","year":"2019","journal-title":"Analyst"},{"key":"10.1016\/j.talanta.2020.121801_bib37","first-page":"344","article-title":"Magnetic particles: from preparation to lab-on-a-chip, biosensors, microsystems and microfluidics applications, Trends","volume":"79","author":"Jamshaid","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121801_bib38","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1039\/b807855f","article-title":"Heterogeneous immunoassays using magnetic beads on a digital microfluidic platform","volume":"8","author":"Sista","year":"2008","journal-title":"Lab Chip"},{"key":"10.1016\/j.talanta.2020.121801_bib39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/ac051720x","article-title":"Gold-coated magnetic particles for solid-phase immunoassays: enhancing immobilized antibody binding efficiency and analytical performance","volume":"78","author":"Zhang","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2020.121801_bib40","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1039\/C4AY02904F","article-title":"A modified quick PETIA for detecting anti-CCP antibodies in human serum","volume":"7","author":"Fu","year":"2015","journal-title":"Anal. Methods."},{"key":"10.1016\/j.talanta.2020.121801_bib41","first-page":"1528","article-title":"Comparison of ELISA and colloidal gold immunochromatographic assay for detection of serum anti-CCP antibody in the diagnosis of RA","volume":"11","author":"Tian","year":"2015","journal-title":"Int. J. Lab. Med."},{"key":"10.1016\/j.talanta.2020.121801_bib42","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.clinbiochem.2011.05.021","article-title":"Performance evaluation of Elecsys analysis system for anti-cyclic citrullinated peptide detection in comparison with commercially available ELISA assays in rheumatoid arthritis diagnosis","volume":"44","author":"Cai","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.talanta.2020.121801_bib43","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/rheumatology\/kep391","article-title":"Evaluation of three automated enzyme immunoassays for detection of anti-cyclic citrullinated peptide antibodies in qualitative and quantitative aspects","volume":"49","author":"Kim","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.talanta.2020.121801_bib44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/10601325.2016.1201756","article-title":"Surface plasmon resonance sensors for real-time detection of cyclic citrullinated peptide antibodies","volume":"53","author":"Dibekkaya","year":"2016","journal-title":"J. Macromol. Sci. A."},{"key":"10.1016\/j.talanta.2020.121801_bib45","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1039\/D0AN00481B","article-title":"Electrochemical biosensor for the simultaneous determination of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in human serum","volume":"145","author":"Guerrero","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.talanta.2020.121801_bib46","article-title":"Highly sensitive immunoassay of anti-cyclic citrullinated peptide marker using surface-enhanced Raman scattering detection","volume":"9523","author":"Chon","year":"2015","journal-title":"Proc. SPIE"},{"key":"10.1016\/j.talanta.2020.121801_bib47","series-title":"National Institute for Biological Standards and Control (NIBSC). WHO Reference Reagent Rheumatoid Arthritis Serum, Human NIBSC Code W1066","year":"2008"},{"key":"10.1016\/j.talanta.2020.121801_bib48","unstructured":"MICROCHEM. SU-8 3000 Permanent Epoxy Negative Photoresist. Accessed 27 February 2020. http:\/\/engineering.dartmouth.edu\/microeng\/processing\/lithography\/SU83000DataSheet.pdf."},{"key":"10.1016\/j.talanta.2020.121801_bib49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev.matsci.28.1.153","article-title":"Soft lithography","volume":"28","author":"Xia","year":"1998","journal-title":"Annu. Rev. Mater. Sci."},{"key":"10.1016\/j.talanta.2020.121801_bib50","unstructured":"Nanoimmunotech. LinkAmine kit MAGNETIC 200 nm (5 mL). Accessed 27 February 2020. https:\/\/www.nanoimmunotech.eu\/en\/Shop\/Bioconjugation-Kits-\/Linkamine-kit-magnetic."},{"key":"10.1016\/j.talanta.2020.121801_bib51","series-title":"The Protein Protocols Handbook","first-page":"7","article-title":"The Lowry method for protein quantitation","author":"Waterborg","year":"2009"},{"key":"10.1016\/j.talanta.2020.121801_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/08982118808962642","article-title":"Variable Gauge repeatability and reproducibility study using the analysis of variance method","volume":"1","author":"Tsai","year":"1998","journal-title":"Qual. Eng."},{"key":"10.1016\/j.talanta.2020.121801_bib54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4103\/0256-4947.57170","article-title":"The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: the predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis","volume":"29","author":"Heidari","year":"2009","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.talanta.2020.121801_bib55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3346\/jkms.2005.20.3.473","article-title":"Diagnostic performances of anti-cyclic citrullinated peptides antibody and antifilaggrin antibody in Korean patients with rheumatoid arthritis","volume":"20","author":"Choi","year":"2005","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.talanta.2020.121801_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5564\/mjc.v15i0.332","article-title":"Biocatalytic properties of horseradish root extract peroxidase (HRP)","volume":"15","author":"Purev","year":"2014","journal-title":"Mong. J. Chem."},{"key":"10.1016\/j.talanta.2020.121801_bib57","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11051-017-4065-6","article-title":"Agglomeration, colloidal stability, and magnetic separation of magnetic nanoparticles: collective influences on environmental engineering applications","volume":"19","author":"Yeap","year":"2017","journal-title":"J. Nanoparticle Res."},{"key":"10.1016\/j.talanta.2020.121801_bib58","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.3390\/ma2042404","article-title":"Surface chemistry in nanoscale materials","volume":"2","author":"Biener","year":"2009","journal-title":"Materials"},{"key":"10.1016\/j.talanta.2020.121801_bib59","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/ar4148","article-title":"Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results forma 1-year prospective study","volume":"15","author":"Bizzaro","year":"2013","journal-title":"Arthritis Res. Ther."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914020310924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914020310924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:45:08Z","timestamp":1758545108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914020310924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":57,"alternative-id":["S0039914020310924"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2020.121801","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microdevice immunoassay with conjugated magnetic nanoparticles for rapid anti-cyclic citrullinated peptide (anti-CCP) detection","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2020.121801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121801"}}